Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 78 entries
Sorted by: Best Match Show Resources per page
Cardiac Surgery in Elderly Patients.

The American journal of geriatric cardiology

Favaloro MR.
PMID: 11416336
Am J Geriatr Cardiol. 1995 May;4(3):13-16.

No abstract available.

Cite
Favaloro MR. Cardiac Surgery in Elderly Patients. Am J Geriatr Cardiol. 1995;4(3):13-16
Favaloro, M. R. (1995). Cardiac Surgery in Elderly Patients. The American journal of geriatric cardiology, 4(3), 13-16.
Favaloro, Mariano R.. "Cardiac Surgery in Elderly Patients." The American journal of geriatric cardiology vol. 4,3 (1995): 13-16.
Favaloro MR. Cardiac Surgery in Elderly Patients. Am J Geriatr Cardiol. 1995 May;4(3):13-16. PMID: 11416336.
Copy Download .nbib Format: NLM
The Journal Impact Factor: don't expect its demise any time soon.

Clinical chemistry and laboratory medicine

Favaloro EJ.
PMID: 19769542
Clin Chem Lab Med. 2009;47(11):1319-24. doi: 10.1515/CCLM.2009.328.

Much emphasis continues to be placed on the Journal Impact Factor (IF), a measure of journal article citation rates, and typically used as a surrogate marker of quality of both the article and journal. The IF is both revered...

Cite
Favaloro EJ. The Journal Impact Factor: don't expect its demise any time soon. Clin Chem Lab Med. 2009;47(11):1319-24doi: 10.1515/CCLM.2009.328.
Favaloro, E. J. (2009). The Journal Impact Factor: don't expect its demise any time soon. Clinical chemistry and laboratory medicine, 47(11), 1319-24. https://doi.org/10.1515/CCLM.2009.328
Favaloro, Emmanuel J. "The Journal Impact Factor: don't expect its demise any time soon." Clinical chemistry and laboratory medicine vol. 47,11 (2009): 1319-24. doi: https://doi.org/10.1515/CCLM.2009.328
Favaloro EJ. The Journal Impact Factor: don't expect its demise any time soon. Clin Chem Lab Med. 2009;47(11):1319-24. doi: 10.1515/CCLM.2009.328. PMID: 19769542.
Copy Download .nbib Format: NLM
Intolerance of uncertainty and conditioned place preference in opioid addiction.

PeerJ

Radell ML, Allen MT, Favaloro B, Myers CE, Haber P, Morley K, Moustafa AA.
PMID: 29844956
PeerJ. 2018 May 21;6:e4775. doi: 10.7717/peerj.4775. eCollection 2018.

Several personality factors have been implicated in vulnerability to addiction by impacting learning and decision making. One such factor is intolerance of uncertainty (IU), the tendency to perceive uncertain situations negatively and avoid them. Conditioned place preference (CPP), which...

Cite
Radell ML, Allen MT, Favaloro B, et al. Intolerance of uncertainty and conditioned place preference in opioid addiction. PeerJ. 2018;6:e4775doi: 10.7717/peerj.4775.
Radell, M. L., Allen, M. T., Favaloro, B., Myers, C. E., Haber, P., Morley, K., & Moustafa, A. A. (2018). Intolerance of uncertainty and conditioned place preference in opioid addiction. PeerJ, 6e4775. https://doi.org/10.7717/peerj.4775
Radell, Milen L, et al. "Intolerance of uncertainty and conditioned place preference in opioid addiction." PeerJ vol. 6 (2018): e4775. doi: https://doi.org/10.7717/peerj.4775
Radell ML, Allen MT, Favaloro B, Myers CE, Haber P, Morley K, Moustafa AA. Intolerance of uncertainty and conditioned place preference in opioid addiction. PeerJ. 2018 May 21;6:e4775. doi: 10.7717/peerj.4775. eCollection 2018. PMID: 29844956; PMCID: PMC5967368.
Copy Download .nbib Format: NLM
2017 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards.

Seminars in thrombosis and hemostasis

Favaloro EJ.
PMID: 29471578
Semin Thromb Hemost. 2018 Mar;44(2):81-88. doi: 10.1055/s-0038-1625982. Epub 2018 Feb 22.

No abstract available.

Cite
Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost. 2018;44(2):81-88doi: 10.1055/s-0038-1625982.
Favaloro, E. J. (2018). 2017 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Seminars in thrombosis and hemostasis, 44(2), 81-88. https://doi.org/10.1055/s-0038-1625982
Favaloro, Emmanuel J. "2017 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards." Seminars in thrombosis and hemostasis vol. 44,2 (2018): 81-88. doi: https://doi.org/10.1055/s-0038-1625982
Favaloro EJ. 2017 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost. 2018 Mar;44(2):81-88. doi: 10.1055/s-0038-1625982. Epub 2018 Feb 22. PMID: 29471578.
Copy Download .nbib Format: NLM
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study).

Journal of thrombosis and thrombolysis

García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, Vílchez JA, Bauça JM, Alcaide Martín MJ, Gutiérrez Garcia I, de la Hera Cagigal P, Egea-Caparrós JM, Pérez Sanmartín S, Gutiérrez Revilla JI, Urrechaga E, Álamo JM, Hernando Holgado AM, Lorenzo-Lozano MC, Canalda Campás M, Juncos Tobarra MA, Morales-Indiano C, Vírseda Chamorro I, Pastor Murcia Y, Sahuquillo Frías L, Altimira Queral L, Nuez-Zaragoza E, Adell Ruiz de León J, Ruiz Ripa A, Salas Gómez-Pablos P, Cebreiros López I, Fernández Uriarte A, Larruzea A, López Yepes ML, Sancho-Rodríguez N, Zamorano Andrés MC, Pedregosa Díaz J, Sáenz L, Esparza Del Valle C, Baamonde Calzada MC, García Muñoz S, Vera M, Martín Torres E, Sánchez Fdez-Pacheco S, Vicente Gutiérrez L, Jiménez Añón L, Pérez Martínez A, Pons Castillo A, González Tamayo R, Férriz Vivancos J, Rodríguez-Fraga O, Díaz-Brito V, Aguadero V, García Arévalo MG, Arnaldos Carrillo M, González Morales M, Núñez Gárate M, Ruiz Iruela C, Esteban Torrella P, Vila Pérez M, Acevedo Alcaraz C, Blázquez-Manzanera AL, Galán Ortega A.
PMID: 34272635
J Thromb Thrombolysis. 2021 Jul 16; doi: 10.1007/s11239-021-02527-y. Epub 2021 Jul 16.

Coagulopathy is a key feature of COVID-19 and D-dimer has been reported as a predictor of severity. However, because D-dimer test results vary considerably among assays, resolving harmonization issues is fundamental to translate findings into clinical practice. In this...

Cite
García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, et al. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis. 2021;doi: 10.1007/s11239-021-02527-y.
García de Guadiana-Romualdo, L., Morell-García, D., Favaloro, E. J., Vílchez, J. A., Bauça, J. M., Alcaide Martín, M. J., Gutiérrez Garcia, I., de la Hera Cagigal, P., Egea-Caparrós, J. M., Pérez Sanmartín, S., Gutiérrez Revilla, J. I., Urrechaga, E., Álamo, J. M., Hernando Holgado, A. M., Lorenzo-Lozano, M. C., Canalda Campás, M., Juncos Tobarra, M. A., Morales-Indiano, C., Vírseda Chamorro, I., Pastor Murcia, Y., Sahuquillo Frías, L., Altimira Queral, L., Nuez-Zaragoza, E., Adell Ruiz de León, J., Ruiz Ripa, A., Salas Gómez-Pablos, P., Cebreiros López, I., Fernández Uriarte, A., Larruzea, A., López Yepes, M. L., Sancho-Rodríguez, N., Zamorano Andrés, M. C., Pedregosa Díaz, J., Sáenz, L., Esparza Del Valle, C., Baamonde Calzada, M. C., García Muñoz, S., Vera, M., Martín Torres, E., Sánchez Fdez-Pacheco, S., Vicente Gutiérrez, L., Jiménez Añón, L., Pérez Martínez, A., Pons Castillo, A., González Tamayo, R., Férriz Vivancos, J., Rodríguez-Fraga, O., Díaz-Brito, V., Aguadero, V., García Arévalo, M. G., Arnaldos Carrillo, M., González Morales, M., Núñez Gárate, M., Ruiz Iruela, C., Esteban Torrella, P., Vila Pérez, M., Acevedo Alcaraz, C., Blázquez-Manzanera, A. L., & Galán Ortega, A. (2021). Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). Journal of thrombosis and thrombolysis, . https://doi.org/10.1007/s11239-021-02527-y
García de Guadiana-Romualdo, Luis, et al. "Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)." Journal of thrombosis and thrombolysis vol. (2021). doi: https://doi.org/10.1007/s11239-021-02527-y
García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, Vílchez JA, Bauça JM, Alcaide Martín MJ, Gutiérrez Garcia I, de la Hera Cagigal P, Egea-Caparrós JM, Pérez Sanmartín S, Gutiérrez Revilla JI, Urrechaga E, Álamo JM, Hernando Holgado AM, Lorenzo-Lozano MC, Canalda Campás M, Juncos Tobarra MA, Morales-Indiano C, Vírseda Chamorro I, Pastor Murcia Y, Sahuquillo Frías L, Altimira Queral L, Nuez-Zaragoza E, Adell Ruiz de León J, Ruiz Ripa A, Salas Gómez-Pablos P, Cebreiros López I, Fernández Uriarte A, Larruzea A, López Yepes ML, Sancho-Rodríguez N, Zamorano Andrés MC, Pedregosa Díaz J, Sáenz L, Esparza Del Valle C, Baamonde Calzada MC, García Muñoz S, Vera M, Martín Torres E, Sánchez Fdez-Pacheco S, Vicente Gutiérrez L, Jiménez Añón L, Pérez Martínez A, Pons Castillo A, González Tamayo R, Férriz Vivancos J, Rodríguez-Fraga O, Díaz-Brito V, Aguadero V, García Arévalo MG, Arnaldos Carrillo M, González Morales M, Núñez Gárate M, Ruiz Iruela C, Esteban Torrella P, Vila Pérez M, Acevedo Alcaraz C, Blázquez-Manzanera AL, Galán Ortega A. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis. 2021 Jul 16; doi: 10.1007/s11239-021-02527-y. Epub 2021 Jul 16. PMID: 34272635; PMCID: PMC8284690.
Copy Download .nbib Format: NLM
The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury.

Journal of thrombosis and thrombolysis

Lippi G, Szergyuk I, de Oliveira MHS, Benoit SW, Benoit JL, Favaloro EJ, Henry BM.
PMID: 34709533
J Thromb Thrombolysis. 2021 Oct 28; doi: 10.1007/s11239-021-02597-y. Epub 2021 Oct 28.

Lipoprotein(a) (Lp(a)) is a prothrombotic and anti-fibrinolytic lipoprotein, whose role has not been clearly defined in the pathogenesis of coronavirus disease 2019 (COVID-19). In this prospective observational study, serum Lp(a) as well as outcomes were measured in 50 COVID-19...

Cite
Lippi G, Szergyuk I, de Oliveira MHS, et al. The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. J Thromb Thrombolysis. 2021;doi: 10.1007/s11239-021-02597-y.
Lippi, G., Szergyuk, I., de Oliveira, M. H. S., Benoit, S. W., Benoit, J. L., Favaloro, E. J., & Henry, B. M. (2021). The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. Journal of thrombosis and thrombolysis, . https://doi.org/10.1007/s11239-021-02597-y
Lippi, Giuseppe, et al. "The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury." Journal of thrombosis and thrombolysis vol. (2021). doi: https://doi.org/10.1007/s11239-021-02597-y
Lippi G, Szergyuk I, de Oliveira MHS, Benoit SW, Benoit JL, Favaloro EJ, Henry BM. The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury. J Thromb Thrombolysis. 2021 Oct 28; doi: 10.1007/s11239-021-02597-y. Epub 2021 Oct 28. PMID: 34709533; PMCID: PMC8552425.
Copy Download .nbib Format: NLM
Sample stability for routine coagulation testing.

Thrombosis research

Favaloro EJ, Mohammed S, Lippi G.
PMID: 32866824
Thromb Res. 2020 Dec;196:130-134. doi: 10.1016/j.thromres.2020.08.025. Epub 2020 Aug 19.

No abstract available.

Cite
Favaloro EJ, Mohammed S, Lippi G. Sample stability for routine coagulation testing. Thromb Res. 2020;196:130-134doi: 10.1016/j.thromres.2020.08.025.
Favaloro, E. J., Mohammed, S., & Lippi, G. (2020). Sample stability for routine coagulation testing. Thrombosis research, 196130-134. https://doi.org/10.1016/j.thromres.2020.08.025
Favaloro, Emmanuel J, et al. "Sample stability for routine coagulation testing." Thrombosis research vol. 196 (2020): 130-134. doi: https://doi.org/10.1016/j.thromres.2020.08.025
Favaloro EJ, Mohammed S, Lippi G. Sample stability for routine coagulation testing. Thromb Res. 2020 Dec;196:130-134. doi: 10.1016/j.thromres.2020.08.025. Epub 2020 Aug 19. PMID: 32866824.
Copy Download .nbib Format: NLM
An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement.

Heliyon

Militi A, Cutroneo G, Favaloro A, Matarese G, Di Mauro D, Lauritano F, Centofanti A, Cervino G, Nicita F, Bramanti A, Rizzo G.
PMID: 31667410
Heliyon. 2019 Oct 04;5(10):e02572. doi: 10.1016/j.heliyon.2019.e02572. eCollection 2019 Oct.

The periodontal ligament (PDL) is a highly vascularized connective tissue surrounding the root of a tooth. In particular, the PDL is continuously exposed to mechanical stresses during the phases of mastication, and it provides physical, sensory, and trophic functions....

Cite
Militi A, Cutroneo G, Favaloro A, et al. An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement. Heliyon. 2019;5(10):e02572doi: 10.1016/j.heliyon.2019.e02572.
Militi, A., Cutroneo, G., Favaloro, A., Matarese, G., Di Mauro, D., Lauritano, F., Centofanti, A., Cervino, G., Nicita, F., Bramanti, A., & Rizzo, G. (2019). An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement. Heliyon, 5(10), e02572. https://doi.org/10.1016/j.heliyon.2019.e02572
Militi, Angela, et al. "An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement." Heliyon vol. 5,10 (2019): e02572. doi: https://doi.org/10.1016/j.heliyon.2019.e02572
Militi A, Cutroneo G, Favaloro A, Matarese G, Di Mauro D, Lauritano F, Centofanti A, Cervino G, Nicita F, Bramanti A, Rizzo G. An immunofluorescence study on VEGF and extracellular matrix proteins in human periodontal ligament during tooth movement. Heliyon. 2019 Oct 04;5(10):e02572. doi: 10.1016/j.heliyon.2019.e02572. eCollection 2019 Oct. PMID: 31667410; PMCID: PMC6812246.
Copy Download .nbib Format: NLM
Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies.

Research and practice in thrombosis and haemostasis

Favaloro EJ.
PMID: 32864548
Res Pract Thromb Haemost. 2020 Jul 15;4(6):952-957. doi: 10.1002/rth2.12392. eCollection 2020 Aug.

No abstract available.

Cite
Favaloro EJ. Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Res Pract Thromb Haemost. 2020;4(6):952-957doi: 10.1002/rth2.12392.
Favaloro, E. J. (2020). Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Research and practice in thrombosis and haemostasis, 4(6), 952-957. https://doi.org/10.1002/rth2.12392
Favaloro, Emmanuel J. "Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies." Research and practice in thrombosis and haemostasis vol. 4,6 (2020): 952-957. doi: https://doi.org/10.1002/rth2.12392
Favaloro EJ. Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies. Res Pract Thromb Haemost. 2020 Jul 15;4(6):952-957. doi: 10.1002/rth2.12392. eCollection 2020 Aug. PMID: 32864548; PMCID: PMC7443425.
Copy Download .nbib Format: NLM
Machine learning and coagulation testing: the next big thing in hemostasis investigations?.

Clinical chemistry and laboratory medicine

Favaloro EJ, Negrini D.
PMID: 33660488
Clin Chem Lab Med. 2021 Mar 03;59(7):1177-1179. doi: 10.1515/cclm-2021-0216.

No abstract available.

Cite
Favaloro EJ, Negrini D. Machine learning and coagulation testing: the next big thing in hemostasis investigations?. Clin Chem Lab Med. 2021;59(7):1177-1179doi: 10.1515/cclm-2021-0216.
Favaloro, E. J., & Negrini, D. (2021). Machine learning and coagulation testing: the next big thing in hemostasis investigations?. Clinical chemistry and laboratory medicine, 59(7), 1177-1179. https://doi.org/10.1515/cclm-2021-0216
Favaloro, Emmanuel J, and Negrini, Davide. "Machine learning and coagulation testing: the next big thing in hemostasis investigations?." Clinical chemistry and laboratory medicine vol. 59,7 (2021): 1177-1179. doi: https://doi.org/10.1515/cclm-2021-0216
Favaloro EJ, Negrini D. Machine learning and coagulation testing: the next big thing in hemostasis investigations?. Clin Chem Lab Med. 2021 Mar 03;59(7):1177-1179. doi: 10.1515/cclm-2021-0216. PMID: 33660488.
Copy Download .nbib Format: NLM
2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines.

Research and practice in thrombosis and haemostasis

Othman M, Favaloro EJ.
PMID: 34977447
Res Pract Thromb Haemost. 2021 Dec 20;5(8):e12635. doi: 10.1002/rth2.12635. eCollection 2021 Dec.

The recent American Society of Hematology/ISTH/National Hemophilia Foundation/World Federation of Hemophilia 2021 guidelines on the diagnosis of von Willebrand disease (VWD) is an outstanding effort to unify the diagnosis of VWD. However, as mentioned in the guidelines, there are...

Cite
Othman M, Favaloro EJ. 2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines. Res Pract Thromb Haemost. 2021;5(8):e12635doi: 10.1002/rth2.12635.
Othman, M., & Favaloro, E. J. (2021). 2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines. Research and practice in thrombosis and haemostasis, 5(8), e12635. https://doi.org/10.1002/rth2.12635
Othman, Maha, and Favaloro, Emmanuel J. "2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines." Research and practice in thrombosis and haemostasis vol. 5,8 (2021): e12635. doi: https://doi.org/10.1002/rth2.12635
Othman M, Favaloro EJ. 2B von Willebrand disease diagnosis: Considerations reflecting on 2021 multisociety guidelines. Res Pract Thromb Haemost. 2021 Dec 20;5(8):e12635. doi: 10.1002/rth2.12635. eCollection 2021 Dec. PMID: 34977447; PMCID: PMC8689114.
Copy Download .nbib Format: NLM
A revival of Paul Dudley White an overview of present medical practice and society. P.D. White International Lecture.

Bratislavske lekarske listy

Favaloro R.
PMID: 11039190
Bratisl Lek Listy. 2000;101(5):247-52.

No abstract available.

Cite
Favaloro R. A revival of Paul Dudley White an overview of present medical practice and society. P.D. White International Lecture. Bratisl Lek Listy. 2000;101(5):247-52
Favaloro, R. (2000). A revival of Paul Dudley White an overview of present medical practice and society. P.D. White International Lecture. Bratislavske lekarske listy, 101(5), 247-52.
Favaloro. "A revival of Paul Dudley White an overview of present medical practice and society. P.D. White International Lecture." Bratislavske lekarske listy vol. 101,5 (2000): 247-52.
Favaloro R. A revival of Paul Dudley White an overview of present medical practice and society. P.D. White International Lecture. Bratisl Lek Listy. 2000;101(5):247-52. PMID: 11039190.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 78 entries